Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 2 | BMC Cancer

Figure 2

From: ECRG4 is a candidate tumor suppressor gene frequently hypermethylated in colorectal carcinoma and glioma

Figure 2

ECRG4 promoter methylation and mRNA expression in primary colorectal carcinoma samples. a) COBRA analysis of ECRG4 methylation in colorectal carcinoma and normal colon tissue samples. Arrows point to restriction fragments indicating a methylated sequence. b) Box plots of methylation percentages of selected colorectal carcinomas and normal colon tissue as determined by Epitect bisulfite sequencing analysis. unmeth = unmethylated; meth = methylated c) Box plots of relative ECRG4 mRNA expression as determined by semiquantitative RT-PCR in colorectal carcinomas relative to normal colon tissue. Note a significantly lower expression in tumor tissue (p = 0.0018). NT = normal colon tissue; CC = colorectal carcinoma.

Back to article page